These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

979 related articles for article (PubMed ID: 27453744)

  • 21. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
    Liu X; Jia R; Zhao J; Li Z
    J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of anti-cyclic citrullinated peptide antibodies with clinical and radiological disease severity in rheumatoid arthritis.
    Gupta A; Kaushik R; Kaushik RM; Saini M; Kakkar R
    Curr Rheumatol Rev; 2014; 10(2):136-43. PubMed ID: 25599684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.
    Hambardzumyan K; Saevarsdottir S; Forslind K; Petersson IF; Wallman JK; Ernestam S; Bolce RJ; van Vollenhoven RF
    Arthritis Rheumatol; 2017 May; 69(5):953-963. PubMed ID: 27992691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis.
    Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Toes RE; Trouw LA; van Schaardenburg D
    Arthritis Rheum; 2013 Apr; 65(4):911-5. PubMed ID: 23279976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Significance and diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody and anti-mutated citrullinated vimentin antibodies in patients with serum negative rheumatoid arthritis].
    Qu SJ; Ye H; Jia RL; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):933-936. PubMed ID: 27987492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment of disease activity in rheumatoid arthritis by multi-biomarker disease activity (MBDA) score].
    Hirata S; Tanaka Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):37-41. PubMed ID: 27181233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients.
    Hjeltnes G; Hollan I; Førre Ø; Wiik A; Mikkelsen K; Agewall S
    Scand J Rheumatol; 2011 Nov; 40(6):422-7. PubMed ID: 22150462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
    Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
    Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Mir-140 and leptin improve the accuracy of the differential diagnosis between psoriatic arthritis and rheumatoid arthritis: a case-control study.
    Cheleschi S; Tenti S; Bedogni G; Fioravanti A
    Transl Res; 2022 Jan; 239():18-34. PubMed ID: 34380068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
    Mathsson L; Mullazehi M; Wick MC; Sjöberg O; van Vollenhoven R; Klareskog L; Rönnelid J
    Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced neutrophil phagocytic capacity in rheumatoid arthritis related to the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptides.
    de Siqueira MB; da Mota LM; Couto SC; Muniz-Junqueira MI
    BMC Musculoskelet Disord; 2015 Jun; 16():159. PubMed ID: 26123215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor.
    Alessandri C; Bartosiewicz I; Pendolino M; Mancini R; Colasanti T; Pecani A; Morello F; Mastrangelo A; Sabatinelli D; Riccieri V; Di Franco M; Ceccarelli F; Perricone C; Conti F; Valesini G
    Clin Exp Rheumatol; 2015; 33(6):824-30. PubMed ID: 26411477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers in Remission According to Different Criteria in Patients with Rheumatoid Arthritis.
    Yilmaz-Oner S; Ozen G; Can M; Atagunduz P; Direskeneli H; Inanc N
    J Rheumatol; 2015 Nov; 42(11):2066-70. PubMed ID: 26472417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort.
    Ranganath VK; Yoon J; Khanna D; Park GS; Furst DE; Elashoff DA; Jawaheer D; Sharp JT; Gold RH; Keystone EC; Paulus HE;
    Ann Rheum Dis; 2007 Dec; 66(12):1633-40. PubMed ID: 17472996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokines (IL-15, IL-21, and IFN-γ) in rheumatoid arthritis: association with positivity to autoantibodies (RF, anti-CCP, anti-MCV, and anti-PADI4) and clinical activity.
    Reyes-Pérez IV; Sánchez-Hernández PE; Muñoz-Valle JF; Martínez-Bonilla GE; García-Iglesias T; González-Díaz V; García-Arellano S; Cerpa-Cruz S; Polanco-Cruz J; Ramírez-Dueñas MG
    Clin Rheumatol; 2019 Nov; 38(11):3061-3071. PubMed ID: 31312989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards a stratified targeted approach with biologic treatments in rheumatoid arthritis: role of synovial pathobiology.
    Astorri E; Nerviani A; Bombardieri M; Pitzalis C
    Curr Pharm Des; 2015; 21(17):2216-24. PubMed ID: 25760296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic Value of Interleukin 6, Interleukin 12P70, Serum Amyloid A, and Procalcitonin for Rheumatoid Arthritis and Their Relationship With the Disease Activity].
    Li F; Wan L; Yan D; Zhang M; Wang S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jul; 55(4):995-1000. PubMed ID: 39170004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.